PAPER Liao X, Qin G, Liu Z, Ren J, Qu X
SEARCH RESULTS
330988 RESULTS
PAPER Zhang X, Liu H, Huang Y, Wang R
A meta-analysis of neurogenic exosomes in the diagnosis of Alzheimer's disease.
Heliyon. 2023 Oct;9(10):e20604. Epub 2023 Oct 4 PubMed: 37817991PAPER Eugenín J, Eugenín-von Bernhardi L, von Bernhardi R
Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases.
Front Mol Neurosci. 2023;16:1249320. Epub 2023 Sep 25 PubMed: 37818457PAPER
Correction to "Young-onset dementia in memory clinics in the Netherlands: Study design and description of PRECODE-GP".
Alzheimers Dement (Amst). 2023;15(4):e12489. Epub 2023 Oct 8 PubMed: 37818172Petr Kocis
Deepa Sathyaseelan
University of Oklahoma Health Sciences CenterUnited States
Selvakumar Govindhasamy Pushpavathi
University of Iowa - Carver College of MedicineIowa city, United States
Development and Optimization of Methods to Diagnose Alzheimer´s Disease Using Blood Tests
JOB 2023-10-11 Employer University of Gothenburg Principal Investigator Henrik Zetterberg Contact laia.montoliu.gaya@gu.se and henrik.zetterberg@clinchem.gu.se Description Approximately 55.2 million individuals worldwide grapple with dementia, a number projected to incr
PAPER Sharma A, Harutyunyan A, Schneider BL, Moszczynska A
Parkin regulates drug-taking behavior in rat model of methamphetamine use disorder.
Transl Psychiatry. 2021 May 17;11(1):293. PubMed: 34001858PAPER Bevan R, Maguire E, Phillips T, Simonazzi E, Vassileva M, Williams J, Taylor P
Uncoupling of synaptic loss from amyloid burden by an Alzheimer's disease protective variant of PLCγ2.
bioRxiv2023.09.22.558987PAPER Romanowska J, Bjornevik K, Cortese M, Tuominen JA, Solheim M, Abolpour Mofrad A, Igland J, Scherzer CR, Riise T
Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study.
Neurology. 2023 Nov 21;101(21):e2068-e2077. Epub 2023 Oct 10 PubMed: 37816645PAPER Aldred J, Freire-Alvarez E, Amelin AV, Antonini A, Bergmans B, Bergquist F, Bouchard M, Budur K, Carroll C, Chaudhuri KR, Criswell SR, Danielsen EH, Gandor F, Jia J, Kimber TE, Mochizuki H, Robieson WZ, Spiegel AM, Standaert DG, Talapala S, Facheris MF, Fung VS
Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
Neurol Ther. 2023 Dec;12(6):1959-1960. PubMed: 37817017PAPER Carroll J, McCann H, Halliday GM, Kwok JB, Dobson-Stone C, Shepherd CE
Poly-GA immunohistochemistry is a reliable tool for detecting C9orf72 hexanucleotide repeat expansions.
Brain Pathol. 2023 Oct 10;:e13216. PubMed: 37816685PAPER Corraliza-Gomez M, Bermejo T, Lilue J, Rodriguez-Iglesias N, Valero J, Cozar-Castellano I, Arranz E, Sanchez D, Ganfornina MD
Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer's disease and brain aging.
J Neuroinflammation. 2023 Oct 11;20(1):233. PubMed: 37817156PAPER Bonomi S, Samara A, Balestra N, Padalia A, Benzinger TL, Kang P
Teaching NeuroImage: Severe Amyloid-Related Imaging Abnormalities After Anti-β-Amyloid Monoclonal Antibody Treatment.
Neurology. 2023 Dec 4;101(23):1079-1080. PubMed: 37816643Current Filters
No filters selected